Thromboxane A2 receptor antagonist SQ29548 attenuates SH‑SY5Y neuroblastoma cell impairments induced by oxidative stressGaoyu Cai(Shanghai Jiao Tong University), Yi Fu(Shanghai Jiao Tong University)International Journal of Molecular MedicineMarch 27, 201810.3892/ijmm.2018.3589Cited by 9SaveCiteExport RISWatch citationsRelated PapersA Randomized, Double‐blind, Placebo‐controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients|Pain Practice|2015|31Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS-induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF-κB signaling pathways|Molecular Medicine Reports|2017|21